Pedro Miguel Rodrigues Leitão

Mr. Pedro Miguel Rodrigues Leitão

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2024 in Cancers
Verified
Journal Article
Open access
PDF file
MVManuel Vinhas
Manuel Vinhas
PLPedro Miguel Rodrigues Leitão
Pedro Miguel Rodrigues Leitão
BRBernardo dos Santos Raimundo
Bernardo dos Santos Raimundo
NGNuno Gil
Nuno Gil
Pedro D. VazPedro D. Vaz
Pedro D. Vaz
FLFernando Luis-Ferreira
Fernando Luis-Ferreira
Volatile organic compounds (VOCs) are an increasingly meaningful method for the early detection of various types of cancers, including lung cancer, through non-invasive methods. Traditional cancer detection techniques such as biopsies, imaging, and blood tests, though effective, often involve invasive procedures or are costly, time consuming, and painful. Recent advancements in technology have led to the exploration of VOC detection as a promising non-invasive and comfortable alternative. VOCs are organic chemicals that have a high vapor pressure at room temperature, making them readily detectable in breath, urine, and skin. The present study leverages artificial intelligence (AI) and machine learning algorithms to enhance classification accuracy and efficiency in detecting lung cancer through VOC analysis collected from exhaled breath air. Unlike other studies that primarily focus on identifying specific compounds, this study takes an agnostic approach, maximizing detection efficiency over the identification of specific compounds focusing on the overall compositional profiles and their differences across groups of patients. The results reported hereby uphold the potential of AI-driven techniques in revolutionizing early cancer detection methodologies towards their implementation in a clinical setting.

16 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
BRBernardo dos Santos Raimundo
Bernardo dos Santos Raimundo
PLPedro Miguel Rodrigues Leitão
Pedro Miguel Rodrigues Leitão
MVManuel Vinhas
Manuel Vinhas
MPMaria Ramos Bárbara de Vasconcelos Pires
Maria Ramos Bárbara de Vasconcelos Pires
LQLaura Bispo Quintas
Laura Bispo Quintas
Pedro D. VazPedro D. Vaz
Pedro D. Vaz
Background: Lung cancer (LC) is the leading cause of cancer-related deaths worldwide. Effective screening strategies for early diagnosis that could improve disease prognosis are lacking. Non-invasive breath analysis of volatile organic compounds (VOC) is a potential method for earlier LC detection. This study explores the association of VOC profiles with artificial intelligence (AI) to achieve a sensitive, specific, and fast method for LC detection. Patients and methods: Exhaled breath air samples were collected from 123 healthy individuals and 73 LC patients at two clinical sites. The enrolled patients had LC diagnosed with different stages. Breath samples were collected before undergoing any treatment, including surgery, and analyzed using gas chromatography coupled to ion-mobility spectrometry (GC-IMS). AI methods classified the overall chromatographic profiles. Results: GC-IMS is highly sensitive, yielding detailed chromatographic profiles. AI methods ranked the sets of exhaled breath profiles across both groups through training and validation steps, while qualitative information was deliberately not taking part nor influencing the results. The K-nearest neighbor (KNN) algorithm classified the groups with an accuracy of 90% (sensitivity = 87%, specificity = 92%). Narrowing the LC group to those only in early-stage IA, the accuracy was 90% (sensitivity = 90%, specificity = 93%). Conclusions: Evaluation of the global exhaled breath profiles using AI algorithms enabled LC detection and demonstrated that qualitative information may not be required, thus easing the frustration that many studies have experienced so far. The results show that this approach coupled with screening protocols may improve earlier detection of LC and hence its prognosis.